RA-V

• UNSPSC Description:

  RA-V is a cyclic hexapeptide. RA-V has activity against Wnt, Myc and Notch with IC50 values of 50, 75, and 93 ng/mL, respectively. RA-V can be used for the research of cancer-related signaling pathways[1].

• Target Antigen:

  c-Myc; Notch; Wnt

• Type:

  Natural Products

• Related Pathways:

  Apoptosis;Neuronal Signaling;Stem Cell/Wnt

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ra-v.html

• Purity:

  99.63

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  OC1=CC=C2C=C1OC3=CC=C(C[C@@]4(N(C([C@H](C)NC([C@@H](N(C([C@H](C)NC([C@@H](C)NC([C@]([H])(C2)N(C)C4=O)=O)=O)=O)C)CC5=CC=C(OC)C=C5)=O)=O)C)[H])C=C3

• Molecular Weight:

  756.84

• References & Citations:

  [1] Premalatha Balachandran, et al. Crosstalk of Cancer Signaling Pathways by Cyclic Hexapeptides and Anthraquinones from Rubia cordifolia. Molecules. 2021 Jan 31;26(3):735.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Clinical Information:

  No Development Reported

• CAS Number:

  64725-24-2